Assessment and follow-up for inclusion into the renal transplantation;Valoración y seguimiento de inclusión en lista de espera para trasplante renal

Nefrologia

Volumn 26, Issue SUPPL.8, 2006, Pages 60-69

  Garcia Garcia M ^a   Oppenheimer, F ^a   Valencia, J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FOLLOW UP; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; KIDNEY TRANSPLANTATION; PRACTICE GUIDELINE; RISK FACTOR;

FOLLOW-UP STUDIES; HEMODIALYSIS UNITS, HOSPITAL; HUMANS; KIDNEY TRANSPLANTATION; RISK FACTORS; WAITING LISTS;

EID: 38449093231     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Roake JA, Cahill AP, Gray DW, Morris PJ. Preemptive cada- veric renal transplantation. Clinical outcome. Transplantation 62: 1411-1416, 1996.
2. Meier-Kriesche HU, Kaplan B. Waiting time on dialysis as the strongest modificable risk factor for renal transplant outco- mes: a paired donor kidney analysis. Transplantation 74: 1377-1381, 2002.
3. Edwards EB, Bennett LE, Cecka JM. Effects of HLA matching on the relative risk of mortality for kidney recipients: a comparison of the mortality risk after transplant to the mortality risk of remaining on the waiting list. Transplantation 64: 1274- 1277, 1997.
4. Schnuelle P, Lorenz D, Trede M, Van der Woude FJ. Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialisis d uring long-term follow-up. J Am Soc Nephrol 9: 2135-2141, 1998.
5. Vela E, Clèries M, the Catalan Committee of the registry of renal patients. Renal transplantation in Catalonia 1984-1997. Transplantation Proc 31: 2354-2357, 1999.
6. Cosio FG, Alamir A, Yim S, et al.: Patient survival after renal transplantation: the impact of dialysis pre-transplant. Kidney Int 53: 767-772, 1998.
7. Kiley DJ, Lam CS, Pollak R. A study of treatment compliance following kidney transplantation. Transplantation 55: 51- 56, 1993.
8. Freeman AM, Westphal JR, Davis LL, Libb JW. The future of organ transplant psyquiatry. Psychosomatics 36: 429-437, 1995.
9. Roodnat JL, Zietse R, Mulder PGH, et al.: The vanishing importance of age in renal transplantation. Transplantation 67: 576-580, 1999.
10. Bonal J, Clèries M, Vela E, The Renal Registry Committee. Transplantation versus haemodialysis in elderly patients. Nephrol Dial Transplant 12: 261-264, 1997.
11. Segoloni GP, Messina M, Tognarelli G, et al.: Survival pro- babilities for renal transplant recipients and dialytic patients: a single center prospective study. Transplant Proc 30: 1739- 1741, 1998.
12. Wolfe RA, Ashby VB, Milford EL, et al.: Comparison of mor- tality in all patients on dialysis, patients on dialysis awaiting transplantation and recipients of a first cadaveric transplant. N Engl J Med 341: 1725-1730, 1999.
13. Kliem V, Kolditz M, Behrend M, et al.: Risk of renal cell car- cinoma after kidney transplantation. Clin Transplant 11: 255- 258, 1997.
14. European best practice guidelines for renal transplantation (Part 1). Nephrol Dial Transplant 15 (Supl. 7): 1-85, 2000.
15. Kasiske BL, Cangro CB, Hariharan S, et al.: The evaluation of renal transplantation candidates: clinical practice guideli- nes. Am J Transplant 1 (Supl. 2): 1-95, 2001.
16. Morales JM, Campistol JM, Andrés A, Rodicio JL, Hepatitis C virus and renal transplantation. Curr Opin Nephrol Hypertens 7: 177-183, 1998.
17. Morales JM, Campistol JM. Transplantation in the patient with hepatitis C. Am Soc Nephrol 11: 1343-1353, 2000.
18. Campistol JM, Esforzado N, Martínez J, et al.: Efficacy and tolerante of interferon-2b in the treatment of chronic hepatitis C Virus infeccion in hemodiálisis patients. Pre and postrenal transplantation assessment. Nephrol Dial Transplant 14: 2704-2709, 1999.
19. Barril G. Hepatitis C virus-induced liver disease in dialysis patients. Nephrol Dial Transplant 15 (8): 42-45, 2000.
20. Barril G, González Parra E, Alcázar R, et al.: Guía sobre enfermedades víricas en hemodiálisis. Nefrología 26 (Supl. 2): 43-66, 2004.
21. Goffin E. Pirson Y, Van Ypersele de Strihou C. Implications of chronic hepatitis B or hepatitis C infeccion for renal transplant candidates. Nephrol Dial Transplant 10: 88-92, 1995.
22. Hammer S, Squires K, Hughes M, et al.: A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficency virus infeccion and CD4 count of 200 per cubic millimetre or less. N Engl J Med 337: 725-733, 1997.
23. Detels R, Muñoz A, McFarlane G, et al.: Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with know HIV infeccion duration. J Am Med Assoc 280: 1497-1503, 1998.
24. Ahuja T, Zingman B, Glicklich D. Long-term survival in an HIV-infected renal transplant recipient. Am J Nephrol 17: 480- 482, 1997.
25. Kumar AM, Damask A, Roland M, et al.: Kidney transplantation in HIV positive end stage renal disease patients- A prospective study. Am J Transplant 2: 174, 2002.
26. Hochegger K, Mayer GJ, Rosenkranz AR. Is HIV infeccion a contraindication for kidney transplantation? Nephrol Dial Transplant 18: 217-218, 2003.
27. Abbot KC, Sawyers ES, Oliver JD III, et al.: Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis 37: 366-373, 2001.
28. Cosyns JP, Couchoud C, Pouteil-Noble C, Squifflet JP, Pirson Y. Recurrente of membranous nephropaty alter renal transplantation: probability, outcome and risk factors. Clin Neph- rol 50: 144-153, 1998.
29. Alexopoulos E. Treatment of primary Ig A nephropathy. Kidney Int 65: 341-355, 2004.
30. Stone JH, Amend WJ, Criswell LA. Outcome of renal transplantation in systemic lupus erytematosus. Semin Arthritis Rheum 27: 17-26, 1997.
31. Meulders Q, Pirson Y, Cosyns JP, Squifflet JP, Van Ypersele de Strihou Ch. Course of Henoch-Schönlein nephritis alter renal transplantation. Transplantation 58: 1172-1186, 1994.
32. Cameron JS. Recurrente primary disease and de novo nephritis following renal transplantation. Pediatr Nephrol 5: 412- 421, 1991.
33. Nachman PH, Segelmark M, Westman K, et al.: Recurrent ANCA-associated small vessel vasculitis after transplantation: A pooled analysis. Kidney Int 56: 1544-1550, 1999.
34. Heering P, Kutkuhm B, Brenzel H, et al.: Renal transplanta- tion in amyloid nephropathy. Int Urol Nephrol 21: 339-343, 1989.
35. Hartmann A, Holdaast H, Fauchald P, et al.: Fifteen years experience with renal transplantation in systemic amyloido- sis. Transplant Int 5: 15-19, 1992.
36. Gerlag PGG, Koene RAP, Berden JHM. Renal Transplantation in light chain nephropathy: case report and review of the literature. Clin Nephrol 25: 101-104, 1986.
37. Najarian JS, Sutherland DER, Simmons RL, et al.: Ten years experience with renal transplantation in juvenil onset diabe- tes. Ann Surg 197: 487-500, 1979.
38. Basadonna G, Matas AJ, Najarian JS, et al.: Transplantation in diabetic patients: the University of Minnesota experience. Kidney Int 42: S193-S198, 1992.
39. Bohman SO, Tyden G, Wilczek H, et al.: Prevention of kidney graft diabetic nephropathy by pancreas transplantation in man. Diabetes 34: 306-308, 1985.
40. Ehrich JHH, Brodehl J, Byrd DJ, et al.: Renal transplantation in 22 children with cystinosis. Pediatr Nephrol 5: 708-714, 1991.
41. Mosnier JF, Degott C, Bedrossian J, et al.: Recurrence of Fabry's disease in a renal allograft eleven years after successful renal transplantation. Transplantation 51: 759-762, 1991.
42. Cochat P. Primary hyperoxaluria type 1. Kidney Int 55: 2533- 2547.
43. Kasike BL, Cangro CB, Hariharan S, et al.: The evaluation of renal transplant candidates: Clinical practice guidelines. Am J Transplant 1 (Supl. 2): 7-95, 2001.
44. Zeier M and Ritz E. Preparation of the dialysis patient for transplantation. Nephrol Dial Transplant 17: 552-556, 2002
45. Ferguson ER, Hudson SL, Diethelm AG, et al.: Outcome after myocardial revascularization and renal transplantation: 25- years single-institution experience. Ann Surg 230: 232-241, 1999.
46. Brekke IB, Lien B, Sodal G, et al.: Aortic reconstruction in preparation for renal transplantation. Transpl Int 6: 161-163, 1993.
47. Savage T, Clarke AL, Giles M, et al.: Calcified plaque is common in the carotid and femoral arteries of dialysis patients without clinical vascular disease. Nephrol Dial Transplant 13: 2004-2012, 1998.
48. Bargallo CM, Pinto A, Gallo S, et al.: Carotid atherosclero- sis in renal transplant recipients: relatioships with cardiovas- cular risk factors and plasma lipoproteins. Transplantation 67: 366-371, 1999.
49. Ting A, Terasaki PI. Lymphocyte-dependent antibody cross- matching for transplant patients. Lancet 1: 304-306, 1975.
50. Schäfer A, Opelz G. Pretransplant antibody screening using lymphocytes frozen in microtest trays. Transplantation 42: 224-225, 1986.
51. Scornik JC, Ireland JE, Howard RJ, et al.: Role of regular and leukocyte-free blood transfusions in the generation of broad sensitization. Transplantation 38: 594-598, 1984.
52. McCune TR, Blanton JW, Thacker LR, Adams PA. The high grade match kidney sharing algorithm of the South-Eastern Organ Procurement Foundation (SEOPF): altering recipient de- mographics through improve matching. Transplantation 64: 860-864, 1997.
53. Rostand SG. Coronary heart disease in chronicrenal inssuffi- ciency: some management considerations. J Am Soc Nephrol 11: 1948-1956, 2000.
54. Sarnak MJ, Levey AS. Epidemiology of cardiac disease in dialysis patients. Semin Dial 12: 69-76, 1999.
55. Truong LD, Krishnan B, Cao JT, et al.: Renal neoplasm in acquired cystic kidney disease. Am J Kidney Dis 26: 1-12, 1995.